FDA Recall
🇺🇸 United States
Completed
2026 recordClass II
House Of Flavors, Inc.
- Product
- 1972 Banana Pudding Ice Cream, 3 GAL, UPC 0 75196 00556 6
- Reason
- Undeclared soy lecithin
- Published
- January 21, 2026
- Distribution
- AL AZ CT GA IA IL IN KY MI MN MO NC NJ N…
View recall →
FDA Recall
🇺🇸 United States
Completed
2026 recordClass II
House Of Flavors, Inc.
- Product
- 2248 Banana Pudding Ice Cream, 3 GAL, UPC 7 65265 81237 8
- Reason
- Undeclared soy lecithin
- Published
- January 21, 2026
- Distribution
- AL AZ CT GA IA IL IN KY MI MN MO NC NJ N…
View recall →
FDA Recall
Ongoing
2026 recordClass II
Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15
by AvKARE
- Reason
- Out of specification for dissolution.
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass I
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4006-9, UPC 787647101887
by Medinatura New Mexico, inc.
- Reason
- Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass I
ReBoost Nasal Spray, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNatura, 10421 Research Rd., SE, Albuquerque, NM 87123, NDC 62795-4005-9, UPC 787647101863
by Medinatura New Mexico, inc.
- Reason
- Microbial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as Achromobacter.
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
by SpecGx, LLC
- Reason
- Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.
by SpecGx, LLC
- Reason
- Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.
by Imprimis NJOF, LLC
- Reason
- Presence of particulate matter - Glass like particles.
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.
by Imprimis NJOF, LLC
- Reason
- Presence of particulate matter - Glass like particles.
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
by Imprimis NJOF, LLC
- Reason
- Presence of particulate matter - Glass like particles.
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass III
Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30
by Alembic Pharmaceuticals Limited
- Reason
- Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
🇺🇸 United States
Ongoing
2026 recordClass II
MAYEJ COMERCIALIZADORA S. de R.L. de C.V.
- Product
- Italian Parsley packaged in 24lb boxes, 40 bunches per box i…
- Reason
- pathogen Cyclospora cayetanensis
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
🇺🇸 United States
Terminated
2026 recordClass II
ZIYAD BROTHERS IMPORTING
- Product
- Baraka Gourmet Pastry Kunafe 6.7oz., UPC 822514291060, 18 re…
- Reason
- May contain partially hydrogenated oils
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
🇺🇸 United States
Terminated
2026 recordClass II
ZIYAD BROTHERS IMPORTING
- Product
- Baraka French Style Puff Pastry 1lb and 1.5lbs sizes, UPCs 8…
- Reason
- May contain partially hydrogenated oils
- Published
- January 14, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
🇺🇸 United States
Ongoing
2026 recordClass II
Town Food Service Equip Co Inc
- Product
- Town Food Service EQ CO Inc. brand Aluminum Sauce Pans in 1Q…
- Reason
- Product found to contain leachable lead levels.
- Published
- January 14, 2026
- Distribution
- AL, AR, AZ, CA, CO, FL, GA, IL, KY, LA,…
View recall →
FDA Recall
Ongoing
2026 recordClass III
traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10
by Zydus Pharmaceuticals (USA) Inc
- Reason
- Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
- Published
- January 7, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13
by Glenmark Pharmaceuticals Inc., USA
- Reason
- Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- Published
- January 7, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14
by Novo Nordisk Inc.
- Reason
- Presence of Particulate Matter: Hair was found in a prefilled syringe
- Published
- January 7, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
by Novo Nordisk Inc.
- Reason
- Presence of Particulate Matter: Hair was found in a prefilled syringe
- Published
- January 7, 2026
- Distribution
- Nationwide
View recall →
FDA Recall
Ongoing
2026 recordClass II
BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG), 2% w/v and Isopropyl alcohol (IPA), 70% v/v), 5.25 mL Applicator, CareFusion 213, LLC, El Paso, TX 79912, NDC 54365-401-29
by CareFusion 213, LLC
- Reason
- Lack of Assurance of Sterlity
- Published
- January 7, 2026
- Distribution
- Nationwide
View recall →
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions.
Read the full medical disclaimer.